Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10424 | 1065 | 26.1 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
222 | 3 | MYOTONIC DYSTROPHY//ALDOSTERONE//PHYSIOLOGY | 49798 |
1248 | 2 | ALDOSTERONE//GITELMAN SYNDROME//BARTTER SYNDROME | 8969 |
10424 | 1 | HYPERKALEMIA//KAYEXALATE//HYPERKALAEMIA | 1065 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HYPERKALEMIA | authKW | 1844249 | 20% | 30% | 211 |
2 | KAYEXALATE | authKW | 394549 | 2% | 81% | 17 |
3 | HYPERKALAEMIA | authKW | 385393 | 4% | 31% | 44 |
4 | PATIROMER | authKW | 289089 | 1% | 92% | 11 |
5 | SODIUM ZIRCONIUM CYCLOSILICATE | authKW | 258031 | 1% | 100% | 9 |
6 | SODIUM POLYSTYRENE SULFONATE | authKW | 204761 | 2% | 36% | 20 |
7 | ZS 9 | authKW | 200691 | 1% | 100% | 7 |
8 | NONOLIGURIC HYPERKALEMIA | authKW | 91743 | 0% | 80% | 4 |
9 | POTASSIUM SUPPLEMENTS | authKW | 86010 | 0% | 100% | 3 |
10 | HYPERPOTASSEMIA | authKW | 65528 | 0% | 57% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 6867 | 24% | 0% | 253 |
2 | Medicine, General & Internal | 2490 | 23% | 0% | 247 |
3 | Emergency Medicine | 975 | 4% | 0% | 45 |
4 | Critical Care Medicine | 488 | 5% | 0% | 48 |
5 | Anesthesiology | 474 | 4% | 0% | 46 |
6 | Pediatrics | 423 | 8% | 0% | 83 |
7 | Transplantation | 297 | 4% | 0% | 41 |
8 | Cardiac & Cardiovascular System | 239 | 7% | 0% | 76 |
9 | Endocrinology & Metabolism | 191 | 6% | 0% | 68 |
10 | Pharmacology & Pharmacy | 85 | 8% | 0% | 84 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVENT CHRISTIAN VILLAGE INC | 28670 | 0% | 100% | 1 |
2 | ANESTHESIE REANIMAT SMURINSERMUMR 942 | 28670 | 0% | 100% | 1 |
3 | ANESTHESIOLCRIT CARE BURN UNITUMR S942 | 28670 | 0% | 100% | 1 |
4 | BEILINSON MED SACKLER MED PEDIAT B | 28670 | 0% | 100% | 1 |
5 | CARDIOLSCI ADVICE WORKING PARTY EUROPEAN MED AGC | 28670 | 0% | 100% | 1 |
6 | CARDIOVASC DRUG DEV INNOVAT | 28670 | 0% | 100% | 1 |
7 | CELLULAR PATHOL SERV DELIVERY UNIT | 28670 | 0% | 100% | 1 |
8 | CHEFARZT ABT ALLGEMEINE INNERE MED NEPHROL | 28670 | 0% | 100% | 1 |
9 | COM MARICOPA BANNER GOOD SAMARITAN MED | 28670 | 0% | 100% | 1 |
10 | CURSO POS EXTENSAO MED INTERNA FDN DESENVOL | 28670 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KIDNEY INTERNATIONAL SUPPLEMENTS | 3752 | 0% | 3% | 4 |
2 | AMERICAN JOURNAL OF NEPHROLOGY | 3172 | 2% | 1% | 19 |
3 | MINERAL AND ELECTROLYTE METABOLISM | 3019 | 1% | 1% | 11 |
4 | AMERICAN JOURNAL OF KIDNEY DISEASES | 2808 | 3% | 0% | 29 |
5 | NEPHRON | 2595 | 2% | 0% | 21 |
6 | ENDOKRINOLOGIE | 1770 | 0% | 2% | 4 |
7 | NEPHROLOGIE & THERAPEUTIQUE | 1578 | 1% | 1% | 6 |
8 | KIDNEY INTERNATIONAL | 1401 | 3% | 0% | 27 |
9 | ARCHIVES OF INTERNAL MEDICINE | 1337 | 2% | 0% | 21 |
10 | CLINICAL NEPHROLOGY | 1283 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYPERKALEMIA | 1844249 | 20% | 30% | 211 | Search HYPERKALEMIA | Search HYPERKALEMIA |
2 | KAYEXALATE | 394549 | 2% | 81% | 17 | Search KAYEXALATE | Search KAYEXALATE |
3 | HYPERKALAEMIA | 385393 | 4% | 31% | 44 | Search HYPERKALAEMIA | Search HYPERKALAEMIA |
4 | PATIROMER | 289089 | 1% | 92% | 11 | Search PATIROMER | Search PATIROMER |
5 | SODIUM ZIRCONIUM CYCLOSILICATE | 258031 | 1% | 100% | 9 | Search SODIUM+ZIRCONIUM+CYCLOSILICATE | Search SODIUM+ZIRCONIUM+CYCLOSILICATE |
6 | SODIUM POLYSTYRENE SULFONATE | 204761 | 2% | 36% | 20 | Search SODIUM+POLYSTYRENE+SULFONATE | Search SODIUM+POLYSTYRENE+SULFONATE |
7 | ZS 9 | 200691 | 1% | 100% | 7 | Search ZS+9 | Search ZS+9 |
8 | NONOLIGURIC HYPERKALEMIA | 91743 | 0% | 80% | 4 | Search NONOLIGURIC+HYPERKALEMIA | Search NONOLIGURIC+HYPERKALEMIA |
9 | POTASSIUM SUPPLEMENTS | 86010 | 0% | 100% | 3 | Search POTASSIUM+SUPPLEMENTS | Search POTASSIUM+SUPPLEMENTS |
10 | HYPERPOTASSEMIA | 65528 | 0% | 57% | 4 | Search HYPERPOTASSEMIA | Search HYPERPOTASSEMIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STERNS, RH , GRIEFF, M , BERNSTEIN, PL , (2016) TREATMENT OF HYPERKALEMIA: SOMETHING OLD, SOMETHING NEW.KIDNEY INTERNATIONAL. VOL. 89. ISSUE 3. P. 546 -554 | 69 | 75% | 6 |
2 | ROSSIGNOL, P , LEGRAND, M , KOSIBOROD, M , HOLLENBERG, SM , PEACOCK, WF , EMMETT, M , EPSTEIN, M , KOVESDY, CP , YILMAZ, MB , STOUGH, WG , ET AL (2016) EMERGENCY MANAGEMENT OF SEVERE HYPERKALEMIA: GUIDELINE FOR BEST PRACTICE AND OPPORTUNITIES FOR THE FUTURE.PHARMACOLOGICAL RESEARCH. VOL. 113. ISSUE . P. 585 -591 | 39 | 95% | 0 |
3 | WEISBERG, LS , (2008) MANAGEMENT OF SEVERE HYPERKALEMIA.CRITICAL CARE MEDICINE. VOL. 36. ISSUE 12. P. 3246-3251 | 45 | 74% | 51 |
4 | WEIR, MR , (2016) CURRENT AND FUTURE TREATMENT OPTIONS FOR MANAGING HYPERKALEMIA.KIDNEY INTERNATIONAL SUPPLEMENTS. VOL. 6. ISSUE 1. P. 29 -34 | 28 | 88% | 2 |
5 | AHMED, J , WEISBERG, LS , (2001) HYPERKALEMIA IN DIALYSIS PATIENTS.SEMINARS IN DIALYSIS. VOL. 14. ISSUE 5. P. 348 -356 | 57 | 63% | 65 |
6 | LINDER, KE , KRAWCZYNSKI, MA , LASKEY, D , (2016) SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9): A NOVEL AGENT FOR THE TREATMENT OF HYPERKALEMIA.PHARMACOTHERAPY. VOL. 36. ISSUE 8. P. 923 -933 | 29 | 91% | 0 |
7 | KOVESDY, CP , (2014) MANAGEMENT OF HYPERKALAEMIA IN CHRONIC KIDNEY DISEASE.NATURE REVIEWS NEPHROLOGY. VOL. 10. ISSUE 11. P. 653 -662 | 37 | 55% | 21 |
8 | HAREL, Z , HAREL, S , SHAH, PS , WALD, R , PERL, J , BELL, CM , (2013) GASTROINTESTINAL ADVERSE EVENTS WITH SODIUM POLYSTYRENE SULFONATE (KAYEXALATE) USE: A SYSTEMATIC REVIEW.AMERICAN JOURNAL OF MEDICINE. VOL. 126. ISSUE 3. P. - | 27 | 90% | 2 |
9 | BATTERINK, J , CESSFORD, TA , TAYLOR, RAI , (2015) PHARMACOLOGICAL INTERVENTIONS FOR THE ACUTE MANAGEMENT OF HYPERKALAEMIA IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 10. P. - | 27 | 87% | 0 |
10 | KOVESDY, CP , (2015) MANAGEMENT OF HYPERKALEMIA: AN UPDATE FOR THE INTERNIST.AMERICAN JOURNAL OF MEDICINE. VOL. 128. ISSUE 12. P. 1281 -1287 | 29 | 73% | 6 |
Classes with closest relation at Level 1 |